Status:
COMPLETED
San Diego Bleeding Esophageal Varices Study
Lead Sponsor:
University of California, San Diego
Conditions:
Survival and Control of Bleeding
Eligibility:
All Genders
Phase:
NA
Brief Summary
In unselected cirrhotic patients with bleeding esophageal varices to compare the influence on mortality rate, duration of life, quality of life, and economic costs of treatment of: * Emergency portac...
Detailed Description
See attached Synopsis - APPENDIX 1
Eligibility Criteria
Inclusion
- All patients with UGI bleeding (blood in the esophagus, stomach, or duodenum) who enter the emergency room or develop bleeding while in the hospital or are transferred from nearby hospitals and are suspected of having cirrhosis and BEV will be eligible for consideration (all comers).
- Those who are shown to have the findings of cirrhosis and esophageal varices that:
- Are seen to be actively bleeding;
- Have an adherent clot;
- Have no other associated lesion that could reasonably account for bleeding of that magnitude (such as large gastric or duodenal varices, GU, DU, etc)
- Require 2 or more units of blood transfusion, will be included in the study.
Exclusion
- None
Key Trial Info
Start Date :
April 1 1988
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
211 Patients enrolled
Trial Details
Trial ID
NCT00690027
Start Date
April 1 1988
End Date
December 1 2005
Last Update
June 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
200 West Arbor Drive
San Diego, California, United States, 92103-8999